Vimta Labs P/E Ratio

VIMTALABS • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
30.93
High Valuation
Very High - High growth expectations or significantly overvalued

Current Valuation Metrics

P/E Ratio 30.93
Current Price ₹380.70
EPS (TTM) ₹18.51
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 8.62
Historical Range 5.16 - 12.24
Percentile 100.0%

Sector Context

Sector Average 47.35
Sector Median 25.62
Sector Rank #11 of 139
Sector Percentile 7.9%

Earnings Breakdown (TTM)

TTM EPS ₹27.65
Sept 2024 ₹6.88
Mar 2024 ₹5.58

Key P/E Ratio Insights for Vimta Labs

  • Stock appears overvalued with PE of 30.93, suggesting caution for new investments
  • Current PE is 258.7% above historical average
  • Trading at discount to sector average PE of 47.35

P/E Ratio Historical Trend for Vimta Labs

Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.

Historical P/E Ratio Data

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2024 7.33 27.65 ₹202.65 NSE Low
2023 12.24 17.71 ₹216.85 NSE Low
2022 9.76 21.4 ₹208.85 NSE Low
2021 5.16 16.84 ₹86.95 NSE Low

Sector P/E Ratio Comparison

Comparing Vimta Labs with other companies in Healthcare sector
Sector Average
47.35
Sector Median
25.62
Lowest P/E
0.9
Highest P/E
898.7
Companies
139
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Welcure Drugs & Pharmace… WELCURE 0.9 ₹31 Low
Murae Organisor MURAE 2.86 ₹41 Low
Ind Swift Laboratories INDSWFTLAB 4.48 ₹1,128 Low
Amwill Health Care AMWILL 5.98 ₹61 Low
Medicamen Organics MEDIORG 6.37 ₹25 Low
Brooks Laboratories BROOKS 6.41 ₹127 Low
Unichem Laboratories UNICHEMLAB 7.14 ₹2,000 Low
Zenith Drugs ZENITHDRUG 7.28 ₹65 Low
Galaxy Medicare GML 7.77 ₹26 Low
Vasundhara Rasayans VRL 9.19 ₹34 Low